MedTrace Logo

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

NCT04650672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2021-11-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of subjects with NV-AMD to perform sequential daily self-imaging of their eyes with the self-operated Notal Home OCT device in their homes for 90 days without on-site supervision. The study will include up to 15 subjects.

Conditions

  • Retinal Neovascularization

Sponsors & Collaborators

  • Notal Vision Inc.

    lead INDUSTRY

Principal Investigators

  • Jeff Heier, MD · Ophthalmic Consultants of Boston, Boston, MA.

  • Nancy Holekamp, MD · Pepose Vision Institute, Chesterfield, MO.

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-08
Primary Completion
2021-08-04
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04650672 on ClinicalTrials.gov